Drug Profile
L 752267
Latest Information Update: 22 Jan 2008
Price :
$50
*
At a glance
- Originator Merck Sharp & Dohme
- Class Antipsychotics
- Mechanism of Action Dopamine D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 19 Jun 2000 No-Development-Reported for Schizophrenia in USA (Unknown route)
- 10 Jul 1997 Preclinical development for Schizophrenia in USA (Unknown route)